Accelerate biomedical innovations. Together.

Too many promising medical innovations never reach the patient due to ever more stringent and difficult landscape of medical devices and cell therapy (GMP), legislation and technical validation.

Medace is committed to bring your innovative (bio)medical concepts to the market and patients faster.

More about Medace

What’s in it for you?

ISO certified quality management system

Access to state of the art specialized infrastructure

Validated equipment

Technical knowhow

ISO and GMP expertise

Dedicated training program by in-house professionals

What do we offer?

We offer a work-learning environment that allows you to develop your technical product dossier needed for clinical validation. At the same time we guide you in how to produce your product according to the ISO and GMP standards.

Download brochureBuild your package

With a broad range of training, expertise and support we provide everything you need to know about regulatory, quality assurance, technical development and so much more. We guide you through the set up and development of technical files. Quality is guaranteed as everything is covered under our overarching ISO certificate.

From flexible office spaces to R&D labs and specialized cleanrooms with validated equipment, a full Quality Management system and trained personnel, at Medace you find everything to develop and manufacture your clinical grade product.

Let’s meet!

Interested to join our community? Got some questions you want answered? Thinking of creating your own space at Medace?

Plan your meeting with CBO Kurt Gielen now.

Let's meet

News and resources

8 January 2021

TissueGUARD speeds up towards clinical trials in 2022 with help of Medace

January 2021 At the start of 2021 Medace welcomes its first German client: TissueGUARD. TissueGUARD provides material innovations for tissue engineering and regenerative medicine applications. The company develops biomaterials for…
1 December 2020

Inocells and Medace achieve swift approval EMA for classification of infertility stem cell therapy

December 2020 Medace aids the Dutch start-up company InoCells to enter the European market with their infertility stem cell therapy. Their therapy has already been approved outside Europe and thanks…
1 December 2020

Press release: Medical face masks from Dutch soil successful through strict testing

Press release -¬†Medical face masks from Dutch soil successful through strict testing¬† Medace, together with one of its clients, makes an important contribution to the safety of healthcare personnel in…
See all news and resources